Skip to main content
    • Aa
    • Aa

Bromodomains as therapeutic targets

  • Susanne Muller (a1), Panagis Filippakopoulos (a1) and Stefan Knapp (a1)

Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biology. Enzymes that ‘write’ (histone acetyltransferases, HATs) and ‘erase’ (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug development, but very few potent inhibitors that modulate the ‘reading process’ mediated by acetyl lysines have been described. The principal readers of ɛ-N-acetyl lysine (Kac) marks are bromodomains (BRDs), which are a diverse family of evolutionary conserved protein-interaction modules. The conserved BRD fold contains a deep, largely hydrophobic acetyl lysine binding site, which represents an attractive pocket for the development of small, pharmaceutically active molecules. Proteins that contain BRDs have been implicated in the development of a large variety of diseases. Recently, two highly potent and selective inhibitors that target BRDs of the BET (bromodomains and extra-terminal) family provided compelling data supporting targeting of these BRDs in inflammation and in an aggressive type of squamous cell carcinoma. It is likely that BRDs will emerge alongside HATs and HDACs as interesting targets for drug development for the large number of diseases that are caused by aberrant acetylation of lysine residues.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Bromodomains as therapeutic targets
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Bromodomains as therapeutic targets
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Bromodomains as therapeutic targets
      Available formats
Re-use permitted under a Creative Commons Licence–by-nc-sa
Corresponding author
*Corresponding author: Stefan Knapp, Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 T. Kouzarides (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO Journal 19, 1176-1179

2 C. Choudhary (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840

3 M. Shogren-Knaak (2006) Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844-847

4 T. Kouzarides (2007) Chromatin modifications and their function. Cell 128, 693-705

5 K.L. Guan and Y. Xiong (2011) Regulation of intermediary metabolism by protein acetylation. Trends in Biochemical Sciences 36, 108-116

6 I. Celic (2006) The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation. Current Biology 16, 1280-1289

7 P. Bertrand (2010) Inside HDAC with HDAC inhibitors. European Journal of Medicinal Chemistry 45, 2095-2116

8 E.M. Bowers (2010) Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chemistry and Biology 17, 471-482

9 S. Mujtaba , L. Zeng and M.M. Zhou (2007) Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26, 5521-5527

10 F. Vollmuth and M. Geyer (2010) Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angewandte Chemie International Edition in English 49, 6768-6772

11 J.W. Tamkun (1992) brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68, 561-572

12 S.R. Haynes (1992) The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Research 20, 2603

13 Z. Nagy and L. Tora (2007) Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 26, 5341-5357

15 S. Malik and S.R. Bhaumik (2010) Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human. FEBS Journal 277, 1805-1821

16 G.D. Gregory (2007) Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Molecular and Cellular Biology 27, 8466-8479

17 V. Bres , S.M. Yoh and K.A. Jones (2008) The multi-tasking P-TEFb complex. Current Opinion in Cell Biology 20, 334-340

18 L. Venturini (1999) TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18, 1209-1217

19 R.H. Jacobson (2000) Structure and function of a human TAF(II)250 double bromodomain module. Science 288, 1422-1425

20 T. Nakamura (2000) huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proceedings of the National Academy of Sciences of the United States of America 97, 7284-7289

21 M. Mohan (2010) Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nature Reviews. Cancer 10, 721-728

22 B.D. Yu (1995) Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378, 505-508

24 K.A. McMahon (2007) Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell 1, 338-345

25 I. Radhakrishnan (1997) Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91, 741-752

26 E. Kalkhoven (2004) CBP and p300: HATs for different occasions. Biochemical Pharmacology 68, 1145-1155

27 Y. Tanaka (2000) Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mechanisms of Development 95, 133-145

28 T.P. Yao (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372

29 P. Bu (2007) Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Molecular and Cellular Biology 27, 3405-3416

30 W. Xu (2000) Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nature Genetics 26, 229-232

31 T. Maurice (2008) Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 33, 1584-1602

32 A.S. Revenko (2010) Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Molecular and Cellular Biology 30, 5260-5272

33 M. Ciro (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Research 69, 8491-8498

34 J.X. Zou (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proceedings of the National Academy of Sciences of the United States of America 104, 18067-18072

35 A. Dey (2000) A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Molecular and Cellular Biology 20, 6537-6549

36 T. Kanno (2004) Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Molecular Cell 13, 33-43

37 A. Dey (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proceedings of the National Academy of Sciences of the United States of America 100, 8758-8763

39 T. Maruyama (2002) A mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Molecular and Cellular Biology 22, 6509-6520

40 S.Y. Wu (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes and Development 20, 2383-2396

41 G.V. Denis (2006) Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. Journal of Proteome Research 5, 502-511

42 G. Leroy , B. Rickards and S.J. Flint (2008) The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Molecular Cell 30, 51-60

43 D. Houzelstein (2002) Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Molecular and Cellular Biology 22, 3794-3802

44 E. Shang (2009) Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Developmental Dynamics 238, 908-917

45 A. Gyuris (2009) The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis. Biochimica Biophysica et Acta 1789, 413-421

46 F. Wang (2010) Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochemical Journal 425, 71-83

47 E. Shang (2007) The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation. Development 134, 3507-3515

48 C. Steilmann (2010) The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men. Reproduction 140, 435-443

49 K.I. Aston (2010) Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent. Human Reproduction 25, 1383-1397

51 M.D. Deato and R. Tjian (2007) Switching of the core transcription machinery during myogenesis. Genes and Development 21, 2137-2149

52 A.M. Buchmann , J.R. Skaar and J.A. DeCaprio (2004) Activation of a DNA damage checkpoint response in a TAF1-defective cell line. Molecular and Cellular Biology 24, 5332-5339

53 C.Y. Lin (2002) The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF. Current Biology 12, 2142-2146

54 J. Kimura (2008) A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress. Nucleic Acids Research 36, 5250-5259

56 A.G. Li (2007) An acetylation switch in p53 mediates holo-TFIID recruitment. Molecular Cell 28, 408-421

57 P.J. Wang and D.C. Page (2002) Functional substitution for TAF(II)250 by a retroposed homolog that is expressed in human spermatogenesis. Human Molecular Genetics 11, 2341-2346

58 C. Kalla (2005) Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes. Genes, Chromosomes and Cancer 42, 128-143

59 V.C. Ramos (2002) Characterisation and expression analysis of the WDR9 gene, located in the Down critical region-2 of the human chromosome 21. Biochimica Biophysica et Acta 1577, 377-383

60 D.L. Philipps (2008) The dual bromodomain and WD repeat-containing mouse protein BRWD1 is required for normal spermiogenesis and the oocyte-embryo transition. Developmental Biology 317, 72-82

61 H. Huang (2003) Expression of the Wdr9 gene and protein products during mouse development. Developmental Dynamics 227, 608-614

62 P. Muller (2005) Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 436, 871-875

63 K.L. Borden (2000) RING domains: master builders of molecular scaffolds? Journal of Molecular Biology 295, 1103-1112

64 G. Meroni and G. Diez-Roux (2005) TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. Bioessays 27, 1147-1157

65 H. Peng , I. Feldman and F.J. Rauscher 3rd (2002) Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression. Journal of Molecular Biology 320, 629-644

68 J.R. Friedman (1996) KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes and Development 10, 2067-2078

70 Y. Li , D.A. Kirschmann and L.L. Wallrath (2002) Does heterochromatin protein 1 always follow code? Proceedings of the National Academy of Sciences of the United States of America 99 (Suppl 4), 16462-16469

71 E. Bartova (2007) Differentiation-specific association of HP1alpha and HP1beta with chromocentres is correlated with clustering of TIF1beta at these sites. Histochemistry and Cell Biology 127, 375-388

72 F. Cammas (2004) Association of the transcriptional corepressor TIF1beta with heterochromatin protein 1 (HP1): an essential role for progression through differentiation. Genes and Development 18, 2147-2160

73 A.V. Ivanov (2007) PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Molecular Cell 28, 823-837

74 L. Zeng (2008) Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nature Structural and Molecular Biology 15, 626-633

75 S. Dupont (2005) Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121, 87-99

76 W. He (2006) Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125, 929-941

77 J. Kim and V. Kaartinen (2008) Generation of mice with a conditional allele for Trim33. Genesis 46, 329-333

78 K. Khetchoumian (2004) TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids. Journal of Biological Chemistry 279, 48329-48341

79 R. Bernardi and P.P. Pandolfi (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nature Reviews. Molecular Cell Biology 8, 1006-1016

80 F.M. Boisvert (2001) The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. Journal of Cell Biology 152, 1099-1106

81 G. Dellaire (2006) Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. Journal of Cell Biology 175, 55-66

82 S. Zhong (1999) A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941-7947

83 F.M. Boisvert , M.J. Hendzel and D.P. Bazett-Jones (2000) Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. Journal of Cell Biology 148, 283-292

84 J. Wang (2004) Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. Journal of Cell Biology 164, 515-526

85 W.S. Wu (2001) The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Molecular and Cellular Biology 21, 2259-2268

86 L.M. Stinton (2011) Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clinical and Experimental Immunology 163, 147-156

87 A.M. Ishov and G.G. Maul (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. Journal of Cell Biology 134, 815-826

89 M. Stern , R. Jensen and I. Herskowitz (1984) Five SWI genes are required for expression of the HO gene in yeast. Journal of Molecular Biology 178, 853-868

90 F. Winston and M. Carlson (1992) Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends in Genetics 8, 387-391

91 P. Sudarsanam (2000) Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America 97, 3364-3369

92 L. Ho (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proceedings of the National Academy of Sciences of the United States of America 106, 5187-5191

93 N. Singhal (2010) Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141, 943-955

94 C.L. Peterson , A. Dingwall and M.P. Scott (1994) Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proceedings of the National Academy of Sciences of the United States of America 91, 2905-2908

95 W. Shen (2007) Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 46, 2100-2110

96 K.A. Link (2005) BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Molecular and Cellular Biology 25, 2200-2215

97 S. Aoyagi , K.W. Trotter and T.K. Archer (2005) ATP-dependent chromatin remodeling complexes and their role in nuclear receptor-dependent transcription in vivo. Vitamins and Hormones 70, 281-307

98 M.B. Debril (2004) Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. Journal of Biological Chemistry 279, 16677-16686

100 S. Pal (2003) mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Molecular and Cellular Biology 23, 7475-7487

101 H.S. Zhang (2000) Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89

102 A. Subtil-Rodriguez and J.C. Reyes (2010) BRG1 helps RNA polymerase II to overcome a nucleosomal barrier during elongation, in vivo. EMBO Reports 11, 751-757

103 B. Lemon (2001) Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. Nature 414, 924-928

104 J. Ryme (2009) Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes. Journal of Cellular Biochemistry 108, 565-576

105 Z. Wang (2004) Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes and Development 18, 3106-3116

106 X. Huang (2008) Coronary development is regulated by ATP-dependent SWI/SNF chromatin remodeling component BAF180. Developmental Biology 319, 258-266

107 A.E. Burrows , A. Smogorzewska and S.J. Elledge (2010) Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proceedings of the National Academy of Sciences of the United States of America 107, 14280-14285

108 R. Bowser , A. Giambrone and P. Davies (1995) FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain. Developmental Neuroscience 17, 20-37

109 M.H. Jones , N. Hamana and M. Shimane (2000) Identification and characterization of BPTF, a novel bromodomain transcription factor. Genomics 63, 35-39

111 D.A. Bochar (2000) A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proceedings of the National Academy of Sciences of the United States of America 97, 1038-1043

112 N. Collins (2002) An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin. Nature Genetics 32, 627-632

113 R.A. Poot (2000) HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins. EMBO Journal 19, 3377-3387

114 R. Strohner (2001) NoRC–a novel member of mammalian ISWI-containing chromatin remodeling machines. EMBO Journal 20, 4892-4900

115 A.G. Ladurner (2003) Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries. Molecular Cell 11, 365-376

116 Y. Zhou and I. Grummt (2005) The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing. Current Biology 15, 1434-1438

117 F. Vollmuth , W. Blankenfeldt and M. Geyer (2009) Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. Journal of Biological Chemistry 284, 36547-36556

118 J. Moriniere (2009) Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 461, 664-668

119 H.D. Huang (2007) Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails. BMC Structural Biology 7, 57

120 T. Umehara (2010) Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. FEBS Letters 584, 3901-3908

121 Y. Liu (2008) Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails. Biochemistry 47, 6403-6417

122 H. Sun (2007) Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochemical and Biophysical Research Communications 358, 435-441

123 L. Zeng (2008) Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure 16, 643-652

124 B.P. Hudson (2000) Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. Journal of Molecular Biology 304, 355-370

125 C. Kupitz , R. Chandrasekaran and M. Thompson (2008) Kinetic analysis of acetylation-dependent Pb1 bromodomain-histone interactions. Biophysical Chemistry 136, 7-12

126 R. Chandrasekaran and M. Thompson (2007) Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions. Biochemical and Biophysical Research Communications 355, 661-666

128 M. Singh (2007) Structural ramification for acetyl–lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex. Chembiochem 8, 1308-1316

129 W.W. Tsai (2010) TRIM24 links a non-canonical histone signature to breast cancer. Nature 468, 927-932

130 J.I. Wu , J. Lessard and G.R. Crabtree (2009) Understanding the words of chromatin regulation. Cell 136, 200-206

131 R. Gamsjaeger (2011) Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3. Molecular and Cellular Biology 31, 2632-2640

132 C.A. French (2001) BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t (15;19). American Journal of Pathology 159, 1987-1992

133 C.A. French (2008) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237-2242

135 N. Reynoird (2010) Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO Journal 29, 2943-2952

136 P. Filippakopoulos (2010) Selective inhibition of BET bromodomains. Nature 468, 1067-1073

137 O.M. Sobulo (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proceedings of the National Academy of Sciences of the United States of America 94, 8732-8737

138 I. Panagopoulos (2001) Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Human Molecular Genetics 10, 395-404

139 L.H. Kasper (1999) CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Molecular and Cellular Biology 19, 764-776

140 K. Deguchi (2003) MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3, 259-271

141 L. Pasqualucci (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189-195

142 J. Bouchal (2011) Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer. Prostate 71, 431-437

143 N.T. Leachman (2010) ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis. Development, Growth and Differentiation 52, 747-755

144 K. Khetchoumian (2007) Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nature Genetics 39, 1500-1506

145 M. Kikuchi (2009) TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochimica Biophysica et Acta 1793, 1828-1836

146 C. Grunwald (2006) Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. International Journal of Cancer 118, 2522-2528

147 M.J. Scanlan (2000) Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Letters 150, 155-164

148 W.G. Tong (2010) Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma. Journal of Clinical Oncology 28, 3015-3022

149 N.P.S. Crawford (2008) Bromodomain 4 activation predicts breast cancer survival. Proceedings of the National Academy of Sciences of the United States of America 105, 6380-6385

150 J. You (2006) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. Journal of Virology 80, 8909-8919

151 M. Weidner-Glunde , M. Ottinger and T.F. Schulz (2010) WHAT do viruses BET on? Frontiers in Bioscience 15, 537-549

152 A. Lin (2008) The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. Journal in Virology 82, 12009-12019

153 E. Nicodeme (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123

154 H. Mahdi (2009) Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nature Genetics 41, 1319-1324

155 S. Rajendrasozhan , H. Yao and I. Rahman (2009) Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 6, 291-297

156 K.C. Choi (2009) Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Molecular Cancer Research 7, 2011-2021

158 W.G. Deng , Y. Zhu and K.K. Wu (2004) Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103, 2135-2142

159 S.J. Cullen , S. Ponnappan and U. Ponnappan (2009) Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes. Molecular Immunology 47, 600-605

160 M.D. Alter and R. Hen (2008) Putting a KAP on transcription and stress. Neuron 60, 733-735

161 J. Jakobsson (2008) KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron 60, 818-831

162 C.R. Bjarkam (2009) Further immunohistochemical characterization of BRD1 a new susceptibility gene for schizophrenia and bipolar affective disorder. Brain and Structure Function 214, 37-47

164 Y. Loe-Mie (2010) SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Human Molecular Genetics 19, 2841-2857

165 M. Koga (2009) Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Human Molecular Genetics 18, 2483-2494

166 C. Rouaux , J.P. Loeffler and A.L. Boutillier (2004) Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochemical Pharmacology 68, 1157-1164

167 N. Zimmermann (2007) Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndrome. European Journal of Human Genetics 15, 837-842

168 J. Viosca (2010) Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein–Taybi syndrome etiology. Neurobiology of Disease 37, 186-194

169 L.M. Valor (2011) Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability. Journal of Neuroscience 31, 1652-1663

170 Y. Oike (1999) Truncated CBP protein leads to classical Rubinstein–Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Human Molecular Genetics 8, 387-396

171 Y. Tanaka (1997) Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein–Taybi syndrome. Proceedings of the National Academy of Sciences of the United States of America 94, 10215-10220

172 C.A. Saura and J. Valero (2011) The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Reviews in Neurosciences 22, 153-169

173 O. Bartsch (2002) Molecular studies in 10 cases of Rubinstein–Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. Journal of Medical Genetics 39, 496-501

174 F. Petrij (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351

175 P. Narayan and M. Dragunow (2010) Pharmacology of epigenetics in brain disorders. British Journal of Pharmacology 159, 285-303

176 Sachchidanand (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chemistry and Biology 13, 81-90

177 D.J. Owen (2000) The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO Journal 19, 6141-6149

178 C.W. Chung (2011) Discovery and characterization of small molecule inhibitors of the BET family bromodomains. Journal of Medicinal Chemistry 54, 3827-3838

179 J.C. Borah (2011) A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chemistry and Biology 18, 531-541

180 L. Zeng (2005) Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. Journal of the American Chemical Society 127, 2376-2377

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 26
Total number of PDF views: 283 *
Loading metrics...

Abstract views

Total abstract views: 487 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 27th July 2017. This data will be updated every 24 hours.